Eli Lilly's Weight-Loss Pill Trials Hit Big Milestone, Temu's App Downloads Plummet in Wake of Tariff War
The Rundown
00:00
Market Reactions to Economic Turbulence and Drug Developments
This chapter reviews recent market shifts triggered by the Federal Reserve Chair's comments, leading to declines in stock indexes. It also explores Eli Lilly's advancements in weight-loss treatments, Timu's struggles with app downloads, and highlights stock performance for companies like Hertz and UnitedHealth Group.
Transcript
Play full episode
